{"id":151979,"date":"2023-08-09T07:56:35","date_gmt":"2023-08-09T11:56:35","guid":{"rendered":"https:\/\/44.250.171.167\/?p=151979"},"modified":"2023-08-09T07:56:36","modified_gmt":"2023-08-09T11:56:36","slug":"granules-india-ltd-q1fy24-62-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q1fy24-62-fall-in-profits\/","title":{"rendered":"Granules India Ltd Q1FY24; 62% fall in Profits"},"content":{"rendered":"<p>Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.<\/p>\n<p><br \/><strong>Financial Results:<\/strong><\/p>\n<ul>\n<li>Granules India Ltd reported Revenues for Q1FY24 of \u20b9986.00 Crores down from \u20b91,020.00 Crore year on year, a fall of 3.33%.<\/li>\n<li>Total Expenses for Q1FY24 of \u20b9920.00 Crores up from \u20b9858.00 Crores year on year, a rise of 7.23%.<\/li>\n<li>Consolidated Net Profit of \u20b948.00 Crores down 62.5% from \u20b9128.00 Crores in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b91.93, down 62.45% from \u20b95.14 in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436-839x1024.png\" alt=\"\" class=\"wp-image-151980\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-436.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish. *The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q1FY24 of \u20b9986.00 Crores down from \u20b91,020.00 Crore year on year, a fall of 3.33%. Total Expenses for Q1FY24 of \u20b9920.00 [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10304],"class_list":["post-151979","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-api"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":152728,"url":"https:\/\/alphastreet.com\/india\/avro-india-ltd-q1fy24-3-fall-in-profits\/","url_meta":{"origin":151979,"position":0},"title":"Avro India Ltd Q1FY24; 3% fall in Profits","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Avro India Ltd is engaged in manufacturing and selling of plastic molded furnitureand granules. It sells its products primarily under its flagship brands i.e. \"AVRO\" and \"AVON\". Financial Results: Avro India Ltd reported Revenues for Q1FY24 of \u20b922.71 Crores up from \u20b920.25 Crore year on year, a rise of 12.15%.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-685.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150817,"url":"https:\/\/alphastreet.com\/india\/dhanuka-agritech-ltd-q1fy24-33-fall-in-profits\/","url_meta":{"origin":151979,"position":1},"title":"Dhanuka Agritech Ltd Q1FY24; 33% fall in Profits.","author":"Divyansh_Kasana","date":"August 2, 2023","format":false,"excerpt":"Dhanuka Agritech manufactures a wide range of agro-chemicals like herbicides, insecticides, fungicides, plant growth regulators in various forms liquid, dust, powder and granules.(Source : 202003 Annual Report Page No:93) Financial Results: Dhanuka Agritech Ltd reported Revenues for Q1FY24 of \u20b9369.00 Crores down from \u20b9393.00 Crore year on year, a fall\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-52.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166149,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q2fy25-5-fall-in-profits\/","url_meta":{"origin":151979,"position":2},"title":"Granules India Ltd Q2FY25; 5% fall in Profits","author":"Divyansh_Kasana","date":"December 24, 2024","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q2FY25 of \u20b9967.00 Crores down from \u20b91,189.00 Crore year on year, a fall of 18.67%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/GRANULES.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166823,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q3fy25-6-fall-in-profits\/","url_meta":{"origin":151979,"position":3},"title":"Granules India Ltd Q3FY25; 6% fall in Profits","author":"Divyansh_Kasana","date":"February 12, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q3FY25 of \u20b91,138.00 Crores down from \u20b91,156.00 Crore year on year, a fall of 1.56%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157250,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q2fy24-30-fall-in-profits\/","url_meta":{"origin":151979,"position":4},"title":"Granules India Ltd Q2FY24; 30% fall in Profits","author":"Divyansh_Kasana","date":"December 12, 2023","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q2FY24 of \u20b91,189.00 Crores up from \u20b91,151.00 Crore year on year, a rise of 3.3%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-82.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162607,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q4fy24-8-rise-in-profits\/","url_meta":{"origin":151979,"position":5},"title":"Granules India Ltd Q4FY24; 8% rise in Profits","author":"Divyansh_Kasana","date":"June 28, 2024","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q4FY24 of \u20b91,176.00 Crores down from \u20b91,196.00 Crore year on year, a fall of 1.67%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-244.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/151979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=151979"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/151979\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=151979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=151979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=151979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}